Associations - PGR positive

PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	Aromatase inhibitor Sensitive: A2 - Guideline Aromatase inhibitor Sensitive : A2	Aromatase inhibitor Sensitive: A2 - Guideline Aromatase inhibitor Sensitive : A2
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	anastrozole Sensitive: A2 - Guideline anastrozole Sensitive : A2	anastrozole Sensitive: A2 - Guideline anastrozole Sensitive : A2
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	megestrol Sensitive: A2 - Guideline megestrol Sensitive : A2	megestrol Sensitive: A2 - Guideline megestrol Sensitive : A2
PGR positive	HER2 Positive Breast Cancer	PGR positive	HER2 Positive Breast Cancer	trastuzumab Sensitive: B - Late Trials trastuzumab Sensitive : B	trastuzumab Sensitive: B - Late Trials trastuzumab Sensitive : B
PGR positive	Uterine Cancer	PGR positive	Uterine Cancer	anastrozole Sensitive: C2 – Inclusion Criteria anastrozole Sensitive : C2	anastrozole Sensitive: C2 – Inclusion Criteria anastrozole Sensitive : C2
PGR positive	HER2 Positive Breast Cancer	PGR positive	HER2 Positive Breast Cancer	AC Sensitive: C3 – Early Trials AC Sensitive : C3	AC Sensitive: C3 – Early Trials AC Sensitive : C3
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	anastrozole Sensitive: C3 – Early Trials anastrozole Sensitive : C3	anastrozole Sensitive: C3 – Early Trials anastrozole Sensitive : C3
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	Aromatase inhibitor Sensitive: C3 – Early Trials Aromatase inhibitor Sensitive : C3	Aromatase inhibitor Sensitive: C3 – Early Trials Aromatase inhibitor Sensitive : C3